Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 131Gastrointestinal Stromal Tumors 67Leukemia 66Leukemia, Myeloid, Chronic-Phase 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Blast Crisis 22Brain Neoplasms 15Philadelphia Chromosome 14Melanoma 13Sarcoma 12Neoplasms 12Neoplasm Metastasis 12Leukemia, Myeloid, Acute 12Leukemia, Myeloid, Accelerated Phase 12Glioblastoma 12Lung Neoplasms 11Prostatic Neoplasms 10Leukemia, Myeloid 9Gliosarcoma 9Glioma 8Breast Neoplasms 8Primary Myelofibrosis 7Leukemia, Myelomonocytic, Chronic 7Central Nervous System Neoplasms 7Astrocytoma 7Recurrence 6Polycythemia Vera 6Ovarian Neoplasms 6Oligodendroglioma 6Myeloproliferative Disorders 6

Interventions

AZD 6244 10trametinib 4pirfenidone 3dabrafenib 2cabozantinib 2Imatinib Mesylate 2tipifarnib 1peginterferon alfa-2b 1nilotinib 1mirdametinib 1cediranib 1binimetinib 1Vinblastine 1Surveys and Questionnaires 1Sorafenib 1Pharmacokinetics 1Methotrexate 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Everolimus 1Cryotherapy 1Control Groups 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neurofibroma, Plexiform × Imatinib Mesylate × Clear all
NCT03688568 2021-02-12

Study of Imatinib in Children With Neurofibromatosis and Airway Tumors

Indiana University

Phase 2 Withdrawn
CNS

Neurofibroma, Plexiform

NCT02177825 2019-04-08

Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas

St. Justine's Hospital

Phase 2 Terminated
5 enrolled
CNS

Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡